| Name | Title | Contact Details |
|---|---|---|
Richard Kaufmann |
Director - Information Security | Profile |
Richard Kaufmann |
SVP and Chief Information Security Officer | Profile |
Keith Blanchard |
Senior Vice President and Chief Technology Officer | Profile |
Martin Howard |
Chief Information Officer | Profile |
Martin Howard |
Chief Information Officer | Profile |
"Eleven uses its proprietary technology platform to create first-of-a-kind protein therapeutics to address unmet needs for ophthalmic diseases. Proteins are able to modulate inflammatory cytokines, key targets in ocular disease that have been difficult to access with conventional therapeutic approaches. A significant untapped opportunity exists for protein therapeutics to address ophthalmic diseases, and Eleven is applying its advanced protein technology and expertise to develop innovative medicines for patients suffering from ocular diseases. Eleven`s team of industry veterans has deep experience in understanding protein science and biologic drug development, designing and conducting clinical trials and, most importantly, applying specific expertise in ophthalmic disease to create novel ocular therapeutics to treat unmet medical needs. Eleven has developed a proprietary pipeline of ophthalmic drug candidates derived from the company`s innovative AMP-Rx protein engineering technology. The company`s initial product candidates are focused on targeting inflammatory cytokines and key targets of ocular disease by blocking the cytokines and modulating the biological processes that drive ocular disease. Current pipeline opportunities include ocular surface diseases such as dry eye disease (DED) and allergic conjunctivitis (AC), and back of the eye diseases such as diabetic macular edema (DME) and uveitis. In addition, Eleven’s proprietary technology has been utilized to prolong the intravitreal half-life of our pipeline products. Beyond its internal drug development programs, Eleven works with collaborators, such as ThromboGenics, to apply its innovative protein therapeutic design capabilities to engineer and develop biotherapeutic products for additional therapeutic targets. EBI-005, Eleven`s lead product candidate, is a novel interleukin-1 (IL-1) receptor antagonist in Phase 3 clinical development as one of the first topically administered proteins for the treatment of DED and AC, two inflammatory diseases at the surface of the eye."
Herbalife Nutrition is a global company that has been changing people`s lives with great nutrition products and a proven business opportunity for its independent distributors since 1980. The Company offers high-quality, science-backed products, sold in over 90 countries by entrepreneurial distributors who provide one-on-one coaching and a supportive community that inspires their customers to embrace a healthier, more active lifestyle. We have over 9,500 employees worldwide and are traded on the New York Stock Exchange (NYSE: HLF) with net sales of approximately $4.9 billion in 2019. To learn more, visit Herbalife.com or IAmHerbalife.com. Financial information is available on ir.herbalife.com We are also proud to sponsor more than 190 world-class athletes, teams and events around the globe, including Cristiano Ronaldo, the LA Galaxy, and numerous Olympic teams. Through our global campaign to eradicate hunger, we are committed to bringing nutrition and education to communities around the world.
National Dental Association is a Washington, DC-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
East Texas Medical Center Regional Healthcare System is one of the leading companies in Healthcare, Pharmaceuticals, and Biotech industry. East Texas Medical Center Regional Healthcare System is based in Tyler, TX. You can find more information on East Texas Medical Center Regional Healthcare System at www.etmc.org
Founded in 2009, Nashville-based Applied Health Analytics, LLC provides software and consulting services to health systems interested in supporting primary care strategies, growing revenue, improving reimbursement quality and creating population-health management initiatives. A joint-venture partner with Vanderbilt University Medical Center`s Dayani Center for Health and Wellness, Applied Health Analytics advances the role of hospitals and health systems as they engage employers to enhance individual health and increase share among commercial populations.